Dr. Andrew is researching clinical trial design for postpartum women with risk of venous thromboembolism (VTE).
NASPAG has created a set of talking points to help health care providers answer questions from parents and adolescents about the safety and efficacy of the Pfizer-BioNtech vaccine.
The CDC has recently released updated statistics about hemophilia characteristics among women and girls receiving care at specialized Hemophilia Treatment Centers (HTCs) in the United States.
Join the World Federation of Hemophilia on Thursday, December 16, 2021 from 8:00-10:00 am EST for a webinar on practical information on bleeding disorders.
The Stop the Clot, Spread the Word® campaign, a joint effort of the National Blood Clot Alliance and the Centers for Disease Control and Prevention, is offering a new toolkit for pregnant women and new moms to highlight the risks of blood clots.
Ming Y. Lim, MBBChir, MSCR received our Research Fellowship Award for a study on von Willebrand disease.
Join FWGBD, ASH, ACOG, AMCHP, & SCDAA for a virtual Congressional Briefing on reproductive health care for women with SCD on Thurs., Oct. 28, from 2-3 pm ET.
Join us on Wednesday, October 13, to honor World Thrombosis Day in partnership with ISTH. World Thrombosis Day (www.worldthrombosisday.org) is a global day of advocacy designed to draw attention to the 1 in 4 people worldwide dying from conditions caused by thrombosis.